1931P Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
Wong, W., Sherman, E.J., Kriplani, A., Michel, L., Zhi, I., Hung, T.K.W., Dunn, L., Grewal, R.K., Krishnamoorthy, G., Ostrovnaya, I., Katabi, N., Fagin, J., Pfister, D., Ho, A.L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
859P Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
Dunn, L., Cracchiolo, J., Ho, A.L., Sherman, E.J., Ganly, I., Ghossein, R., Cohen, M., Wong, W., Desilets, A., Michel, L., Kriplani, A., Hung, T.K.W., Singh, B., Boyle, J., Morris, L., McBride, S., Riaz, N., Lee, N., Wong, R., Pfister, D.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article